ArticleStem cell research & therapy2025
Epigenetic memory as a readout of environmental susceptibility defines cell manufacturability in mesenchymal stem cell production.
Article in Stem cell research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundMesenchymal stem cells (MSCs) are highly sensitive to fluctuations in culture process parameters (CPPs), which remain a major barrier to consistent product quality in cell manufacturing. A mechanistic understanding of how cells respond to and encode these variations is essential to enable standardization under a quality-by-design paradigm.
methodsTo address this, we propose the concept of cell manufacturability, defined as the intrinsic ability of cells to maintain their functional phenotype in response to variable inputs. Drawing inspiration from the Japanese concept of yuragi (gentle, adaptive fluctuation), we profiled histone modifications (H3K4me3 and H3K27me3) at the promoters of critical quality attribute (CQA) genes using chromatin immunoprecipitation followed by quantitative PCR (ChIP-qPCR). We established a cell potency index based on the H3K4me3/H3K27me3 ratio. Weighted principal component analysis (PCA) was applied to derive two composite indices: the Cell Susceptibility Index (CSI), indicating environmental responsiveness, and the Cell Comparability Index (CCI), representing inter-donor and process consistency.
resultsThe CSI and CCI captured distinct, condition-dependent patterns. Under low-stress conditions (e.g., early passages and low seeding density), a positive correlation between CSI and CCI reflected reproducible adaptive plasticity. Conversely, high-stress cultures exhibited a strong negative correlation, which was indicative of unstable epigenetic responses. These patterns were consistently observed across different MSC sources, underscoring the generalizability of the framework.
conclusionsThis study highlights CSI and CCI as quantitative, chromatin-based metrics that offer a mechanistic basis for characterizing MSC plasticity and manufacturing robustness. Integration of these indices into the evaluation of cell manufacturability offers a predictive and scalable approach to enhance standardization and batch comparability in MSC production processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.